Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on August 27, 2025
Supernus Pharmaceuticals to Participate in September Investor Conferences
GlobeNewswire
·
August 27, 2025
ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today …
Anaptys Announces Participation in September Investor Conferences
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of …
Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025
GlobeNewswire
·
August 27, 2025
AURORA, Colo., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (“Bespoke” or the “Company”) (OTCQB: BSPK), today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Andrew Ross Joins Symbotic’s Board of Directors
GlobeNewswire
·
August 27, 2025
WILMINGTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the election of Andrew (“Andy”) Ross to its Board of Directors, effective August 26, 2025. …
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
GlobeNewswire
·
August 27, 2025
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
GlobeNewswire
·
August 27, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …
HP Inc. Reports Fiscal 2025 Third Quarter Results
GlobeNewswire
·
August 27, 2025
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.80, up 23.1% from the prior year period Third quarter non-GAAP diluted net EPS of $0.75, down 10.7% from the prior year …
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
GlobeNewswire
·
August 27, 2025
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its …
MDB Capital Holdings Provides Second Quarter 2025 Update
GlobeNewswire
·
August 27, 2025
Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025 …
Lantronix Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire
·
August 27, 2025
Fourth Quarter 2025 Net Revenue of $28.8 Million Fourth Quarter 2025 GAAP EPS of ($0.07) Fourth Quarter 2025 Non-GAAP EPS of $0.01 IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity …
Key Tronic Corporation Announces Results for the Fourth Quarter and Year End of Fiscal Year 2025
GlobeNewswire
·
August 27, 2025
SPOKANE VALLEY, Wash., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its results for the quarter ended June 28, 2025. For the fourth quarter of fiscal year …
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 27, 2025
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025, in New York, …
Finanz Informatik Signs Long-Term Contract with Nutanix
GlobeNewswire
·
August 27, 2025
SAN JOSE, Calif. and FRANKFURT, Germany, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, and Finanz Informatik (FI), today announced that they have decided to enter into a strategic collaboration and have …
Nutanix Announces Increase to Share Repurchase Authorization
GlobeNewswire
·
August 27, 2025
SAN JOSE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its Board of Directors has authorized an increase of $350 million of common stock to the company’s existing share …
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …
Nutanix Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
August 27, 2025
Reports 18% YoY Revenue Growth and Strong Free Cash Flow for Fiscal 2025 Delivers Outperformance Across All Guided Metrics SAN JOSE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today …